Literature DB >> 15527548

Src-kinase-dependent epidermal growth factor receptor transactivation in salivary mucin secretion in response to beta-adrenergic G-protein-coupled receptor activation.

Bronislaw L Slomiany1, Amalia Slomiany.   

Abstract

The principal regulatory factors that control the flow and make-up of salivary secretion are neurotransmitters, released by parasympathetic and sympathetic innervation, that trigger activation of G protein-coupled receptors (GPCRs) on the acinar cells of salivary glands and stimulate the generation of soluble second messengers. In this study, we report that activation of GPCR by beta-adrenergic agonist leading to stimulation in salivary mucin secretion occurs with the involvement of epidermal growth factor receptor (EGFR). Using [(3)H]glucosamine-labeled mucous acinar cells of sublingual salivary gland in culture, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited in a concentration-dependent manner by EGFR kinase inhibitor, PD153035, as well as wortmannin, an inhibitor of PI3K. Moreover, both inhibitors caused the impedance in the acinar cell mucin secretory responses to beta-adrenergic agonist-generated second messenger, cAMP, as well as adenylate cyclase activator, forskolin. The acinar cell secretory responses to isoproterenol, furthermore, were blunted in a concentration-dependent fashion by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation. However, no significant alterations in the acinar cell mucin secretory responses to isoproterenol, cAMP or forskolin were attained with an inhibitor of the ERK pathway, PD98059. Our findings underline the role of EGFR as a convergence point in modulation of salivary mucin secretion triggered by beta-adrenergic agonist GPCR activation and demonstrate the importance of Src kinase in the EGFR transactivation process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527548     DOI: 10.1163/1568560042342329

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  6 in total

1.  Subcellular localization of epidermal growth factor receptor in human submandibular gland.

Authors:  M S Lantini; M Cossu; M Isola; M Piras; M Piludu
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

2.  Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways.

Authors:  Lida Q Fuentes; Carlos E Reyes; José M Sarmiento; Carolina I Villanueva; Carlos D Figueroa; Javier Navarro; Carlos B González
Journal:  Cell Signal       Date:  2008-05-25       Impact factor: 4.315

3.  Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

Authors:  Thomas E Reznik; Yingying Sang; Yongxian Ma; Roger Abounader; Eliot M Rosen; Shuli Xia; John Laterra
Journal:  Mol Cancer Res       Date:  2008-01       Impact factor: 5.852

4.  Characterization of the alpha1-adrenoceptor subtype activating extracellular signal-regulated kinase in submandibular gland acinar cells.

Authors:  Michael R Bruchas; Myron L Toews; Charles S Bockman; Peter W Abel
Journal:  Eur J Pharmacol       Date:  2007-10-02       Impact factor: 4.432

Review 5.  The Role of Nitrosamine (NNK) in Breast Cancer Carcinogenesis.

Authors:  Nomundelger Gankhuyag; Kang-Hoon Lee; Je-Yoel Cho
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-06-29       Impact factor: 2.673

Review 6.  β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma.

Authors:  George Zaki Ghali; Michael George Zaki Ghali
Journal:  Mol Biol Rep       Date:  2020-04-18       Impact factor: 2.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.